RNA

ATRIUM THERAPEUTICS INC

RNA·04965N104·US·Common Stock-13D/G

RNA (ATRIUM THERAPEUTICS INC) is held by 81 institutional investors as of Q2 2026. Largest holders: PRICE T ROWE ASSOCIATES INC /MD/ ($19.8M), BlackRock, Inc. ($19.5M), VANGUARD CAPITAL MANAGEMENT LLC ($9.8M). Net institutional sentiment: Mixed.

81
Holders
(5 Elite)
$113.5M
Total Value
46% (85)
Consensus
39 buying - 46 selling
13F: Insider & Congress: Updated regularly
RNA

Smart Money Verdict

View all
Loading verdict
Held by 81 funds
5 elite

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Sep 22, 2026 · Activists Aug 14, 2026 · Congress none

InsiderKSKenney StephanieTax 2K shSep 18, 2026
InsiderHMHoyos Rocio MartinTax 8K shSep 18, 2026
InsiderYHYounis HusamTax 11K shSep 18, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
1.5M(-5.2%)$19.8M0.0%-47.61%
0
Increased
1.4M(+20.1%)$19.5M0.0%-46.33%
34
Increased
730,831(+16.6%)$9.8M0.0%-46.53%
32
Increased
386,929(+21.0%)$5.2M0.0%-46.29%
32
Increased
345,481(+93.5%)$4.6M0.0%-43.76%
43
Decreased
310,341(-11.3%)$4.2M0.0%-47.61%
0
Increased
271,762(+5.7%)$3.7M0.0%-47.20%
28
Increased
256,917(+9.0%)$3.5M0.0%-46.98%
29
Increased
200,559(+5.1%)$2.7M0.0%-47.25%
28
Increased
199,158(+22.4%)$2.7M0.0%-46.21%
32
New
172,235$2.3M0.0%-38.96%
36
Decreased
146,743(-36.6%)$2M0.0%-47.61%
0
Increased
137,394(+0.0%)$1.8M0.0%-47.61%
26
Decreased
132,833(-2.5%)$1.8M0.0%-47.61%
0
Increased
130,217(+11.7%)$1.8M0.0%-46.82%
29
Increased
129,591(+81.6%)$1.7M0.0%-44.04%
40
Increased
119,781(+21.5%)$1.6M0.0%-46.26%
31
Increased
117,275(+51.4%)$1.6M0.0%-44.96%
36
Unchanged
111,200$1.5M0.0%-47.61%
0
Increased
109,961(+15.6%)$1.5M0.0%-46.59%
29

Showing 1-20 of 100

1 / 5
RNARNAATRIUM THERAPEUTICS INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used